Abstract
Biomarker Driven Umbrella Trial of Crenolanib in Combination with Ivosidenib, Enasidenib, Venetoclax, Vyxeos and/or Salvage Chemotherapy in FLT3 Mutant AML
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have